Author [Ref.] | Year | Location | Study design | Type of sample | No. of case | No. of control | No. of case positive | No. of control positive |
---|---|---|---|---|---|---|---|---|
Rowlands [29] | 1993 | UK and Japan | Cross-sectional | FFPE | 174 | Â | 9 | Â |
Shibata [30] | 1993 | USA | Cross-sectional | FFPE | 187 | Â | 19 | Â |
Tokunaga [31] | 1993 | Japan | Cross-sectional | FFPE | 1848 | Â | 122 | Â |
Tokunaga [32] | 1993 | Japan | Cross-sectional | FFPE | 999 | Â | 69 | Â |
Imai [33] | 1994 | Japan | Case-control | FFPE | 1000 | 1000 | 70 | 0 |
Ott [34] | 1994 | Germany | Case-control | FFPE | 39 | 39 | 7 | 0 |
Shousha [35] | 1994 | UK | Case-control | FFPE | 19 | 9 | 1 | 5 |
Yuen [36] | 1994 | China | Case-control | FFPE | 74 | 36 | 7 | 0 |
Harn [37] | 1995 | Taiwan | Case-control | FFPE | 55 | 49 | 6 | 0 |
Gulley [38] | 1996 | USA | Case-control | FFPE | 95 | 95 | 11 | 0 |
Moritani [39] | 1996 | Japan | Case-control | FFPE | 132 | 132 | 15 | 0 |
Selves [40] | 1996 | France | Case-control | FFPE | 59 | 59 | 5 | 0 |
Shin [41] | 1996 | South Korea | Case-control | FFPE | 89 | 37 | 12 | 0 |
Galetsky [42] | 1997 | Russia | Case-control | FFPE | 206 | 206 | 18 | 0 |
Clark [43] | 1997 | Singapore | Cross-sectional | FFPE | 137 | Â | 6 | Â |
Ojima [44] | 1997 | Japan | Cross-sectional | FFPE | 412 | Â | 83 | Â |
Yanai [45] | 1997 | Japan | Cross-sectional | FFPE | 124 | Â | 12 | Â |
Herrera-Goepfert [46] | 1999 | Mexico | Cross-sectional | FFPE | 135 | Â | 11 | Â |
Kume [47] | 1999 | Japan | Case-control | FFPE | 344 | 344 | 40 | 0 |
Takano [48] | 1999 | Japan | Cross-sectional | FFPE | 513 | Â | 33 | Â |
Wan [49] | 1999 | China | Case-control | FFPE | 58 | 58 | 6 | 0 |
Chapel [50] | 2000 | France | Case-control | FFPE | 56 | 56 | 7 | 0 |
Wu [51] | 2000 | Taiwan | Cross-sectional | Biopsy | 150 | Â | 30 | Â |
Corvalan [52] | 2001 | Chile | Case-control | FFPE | 185 | 185 | 31 | 0 |
Kijima [53] | 2001 | Japan | Cross-sectional | FFPE | 313 | Â | 23 | Â |
Ishii [54] | 2001 | Japan | Cross-sectional | FFPE | 119 | Â | 23 | Â |
Koriyama [55] | 2001 | Brazil | Cross-sectional | FFPE | 300 | Â | 24 | Â |
Luqmani [56] | 2001 | UK | Case-control | FFPE | 20 | 79 | 1 | 9 |
Burgess [57] | 2002 | UK | Cross-sectional | FFPE | 534 | Â | 9 | Â |
Kang [58] | 2002 | South Korea | Cross-sectional | FFPE | 233 | Â | 21 | Â |
Kattoor [59] | 2002 | India and Japan | Cross-sectional | FFPE | 2226 | Â | 135 | Â |
Vo [60] | 2002 | USA | Cross-sectional | FFPE | 107 | Â | 11 | Â |
Czopek [61] | 2003 | Poland | Cross-sectional | FFPE | 40 | Â | 5 | Â |
Oda [62] | 2003 | Japan | Case-control | FFPE | 97 | 97 | 5 | 0 |
Ishii [63] | 2004 | Japan | Case-control | FFPE | 133 | 133 | 19 | 0 |
Lee [64] | 2004 | South Korea | Cross-sectional | FFPE | 1127 | Â | 63 | Â |
Lopes [65] | 2004 | Brazil | Case-control | FFPE | 53 | 53 | 6 | 0 |
van Beek [66] | 2004 | Netherlands | Cross-sectional | FFPE | 566 | Â | 41 | Â |
Alipov [67] | 2005 | Kazakhstan | Case-control | FFPE | 139 | 139 | 14 | 0 |
Herrera-Goepfert [68] | 2005 | Mexico | Case-control | FFPE | 330 | 330 | 24 | 2 |
Luo [69] | 2005 | China | Case-control | FFPE | 172 | 172 | 11 | 0 |
Yoshiwara [70] | 2005 | Peru | Cross-sectional | FFPE | 254 | Â | 10 | Â |
Campos [71] | 2006 | Colombia | Cross-sectional | FFPE | 368 | Â | 42 | Â |
Szkaradkiewicz [72] | 2006 | Poland | Cross-sectional | FFPE | 32 | Â | 14 | Â |
Luo [73] | 2006 | China | Cross-sectional | FFPE | 185 | Â | 13 | Â |
von Rahden [74] | 2006 | Germany | Case-control | FFPE | 82 | 82 | 5 | 0 |
Abdirad [75] | 2007 | Iran | Cross-sectional | FFPE | 273 | Â | 9 | Â |
Jung [76] | 2007 | South Korea | Cross-sectional | FFPE | 111 | Â | 7 | Â |
Lima [77] | 2008 | Brazil | Cross-sectional | FFPE | 71 | Â | 6 | Â |
Ryan [78] | 2009 | USA | Cross-sectional | FFPE | 113 | Â | 11 | Â |
Trimeche [79] | 2009 | Tunisia | Cross-sectional | FFPE | 96 | Â | 4 | Â |
Truong [80] | 2009 | USA | Case-control | FFPE | 235 | 72 | 12 | 0 |
Ferrasi [81] | 2010 | Brazil | Case-control | FFPE | 54 | 54 | 5 | 0 |
Koriyama [82] | 2010 | Japan | Cross-sectional | FFPE | 156 | Â | 21 | Â |
Chen [83] | 2010 | China | Case-control | FFPE | 676 | 676 | 45 | 3 |
Boysen [84] | 2011 | Denmark | Cross-sectional | FFPE | 131 | Â | 10 | Â |
BenAyed-Guerfali [2] | 2011 | Tunisia | Cross-sectional | FFPE | 81 | Â | 12 | Â |
de Lima [85] | 2012 | Brazil | Cross-sectional | FFPE | 160 | Â | 11 | Â |
Ksiaa [86] | 2014 | Tunisia | Cross-sectional | FFPE | 43 | Â | 4 | Â |
Aslane [87] | 2016 | Algeria | Case-control | FFPE | 97 | 10 | 22 | 0 |
Tsai [88] | 2016 | Taiwan | Cross-sectional | FFPE | 1039 | Â | 52 | Â |
Zhang [89] | 2016 | China | Cross-sectional | FFPE | 600 | Â | 30 | Â |
Liu [90] | 2016 | China | Case-control | FFPE | 206 | 206 | 15 | 0 |
Na [91] | 2017 | South Korea | Cross-sectional | FFPE | 205 | Â | 15 | Â |
Boger [92] | 2017 | Germany | Cross-sectional | FFPE | 484 | Â | 22 | Â |
Kim [93] | 2017 | South Korea | Case-control | FFPE | 207 | 56 | 13 | 0 |
Nogueira [94] | 2017 | Portugal | Case-control | FFPE | 82 | 33 | 9 | 1 |
Ribeiro [3] | 2017 | Portugal | Cross-sectional | FFPE | 179 | Â | 15 | Â |
de Souza [95] | 2018 | Brazil | Cross-sectional | Biopsy | 302 | Â | 62 | Â |
Wanvimonsuk [96] | 2018 | Thailand | Case-control | FFPE | 33 | 55 | 4 | 0 |
Martinez-Ciarpaglini [97] | 2019 | Spain | Cross-sectional | FFPE | 209 | Â | 13 | Â |